Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.

Falchi L., Nijland M., Huang H., Linton K. M., Seymour J. F., Tao R., ...Daha Fazla

Lancet (London, England), cilt.407, sa.10524, ss.161-173, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 407 Sayı: 10524
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/s0140-6736(25)02360-8
  • Dergi Adı: Lancet (London, England)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Abstracts in Social Gerontology, Artic & Antarctic Regions, BIOSIS, CINAHL, EMBASE, MEDLINE, Psycinfo, Public Affairs Index, Nature Index
  • Sayfa Sayıları: ss.161-173
  • Ankara Üniversitesi Adresli: Evet

Özet

This paper has been written to mark 25 years of operational medium-range ensemble forecasting. The origins of the ECMWF Ensemble Prediction System are outlined, including the development of the precursor real-time Met Office monthly ensemble forecast system. In particular, the reasons for the development of singular vectors and stochastic physics - particular features of the ECMWF Ensemble Prediction System - are discussed. The author speculates about the development and use of ensemble prediction in the next 25 years.